ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,045 | +5.0% | 12,303 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $41,937 | +11.5% | 11,365 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $37,618 | -16.2% | 11,365 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $44,872 | +157.8% | 11,565 | +61.5% | 0.00% | +100.0% |
| Q3 2022 | $17,404 | -22.9% | 7,162 | -37.2% | 0.00% | 0.0% |
| Q2 2022 | $22,580 | -69.9% | 11,404 | -56.3% | 0.00% | -50.0% |
| Q1 2020 | $75,096 | -11.8% | 26,075 | +36.3% | 0.00% | +100.0% |
| Q3 2019 | $85,106 | – | 19,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |